This company always said the FDA pathway was their top priority. Ira has failed in fulfilling his major responsibility. No matter what is the answer from EMA, Ira has been proven to be overpaid.
- Forums
- ASX - By Stock
- Dr Ira
This company always said the FDA pathway was their top priority....
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $8.75K | 1.75M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 63306661 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 28430837 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 62431661 | 0.004 |
47 | 46138652 | 0.003 |
17 | 39764402 | 0.002 |
13 | 92470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 28430837 | 21 |
0.006 | 34263249 | 13 |
0.007 | 22226649 | 17 |
0.008 | 14274594 | 13 |
0.009 | 6000000 | 5 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |